Echo Therapeutics Company Culture
Echo Therapeutics Culture
This score is derived from employee ratings & reviewsTop Rated Culture Dimensions
Share Your Opinion
Anonymously Rate Your Experience & Make Work BetterEcho Therapeutics Company Information
Echo Therapeutics Company Overview
Echo Therapeutics develops the Symphony tCGM System, a novel, non-invasive (needle-free) glucose monitoring system for diabetes patients.
| Headquarter | 8 Penn Center 1628 JFK Boulevard, Suite 300 Philadelphia, PA United States of America |
|---|---|
| Website | www.echotx.com |
| Founding Date | 1989 |
| Tel | (215) 717-4100 |
| Company Status | Public |
Echo Therapeutics Competitors
Echo Therapeutics competitors include Insulet Corporation and OneDrop. See below how Echo Therapeutics compares to its competitors with CEO Rankings, Product & Services, NPS, Pricing, Customer Services, Overall Culture Score, eNPS, Gender and Diversity Scores.
Echo Therapeutics Careers
Echo Therapeutics Jobs
No Recent Jobs found for Echo Therapeutics on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably
Let Echo Therapeutics Know You Want To Work There
Frequently Asked Questions regarding Echo Therapeutics
What is Echo Therapeutics address?
Echo Therapeutics location is at 8 Penn Center 1628 JFK Boulevard, Suite 300
Who are Echo Therapeutics competitors?
Echo Therapeutics main competitors are Insulet Corporation, OneDrop
Who is Echo Therapeutics leadership?
are part of Echo Therapeutics leadership, Scott Hollander is the CEO
×